© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ECHO
Anti-chromatin antibodies are a useful marker for lupus nephropathy
| The first 150 words of the full text of this article appear below. |
Anti-chromatin antibodies, measured by ELISA, can be detected in 69% of patients with systemic lupus erythematosus (SLE) but only 710% of those with primary Sjogrens syndrome, systemic sclerosis, and primary antiphospholipid syndrome (APS). The antibody was not present in 100 healthy blood donors, acting as controls.
Of the patients with SLE, 52 of 100 had evidence of lupus nephropathy and 42 of these were positive for anti-chromatin antibody, yielding a sensitivity of these antibodies for lupus nephritis of 81% and a specificity of 39%. The mean level was 68U in those with nephropathy and 42U in those without. There was a significant correlation between disease activity and antibody level (R2=0.0689).
Anti-chromatin antibodies did not correlate with the presence of ANA, antiphospholipid antibodies or rheumatoid factor. Using the Farr assay, six samples were anti-dsDNA positive but anti-chromatin antibody negative, possibly because some antibodies recognise structures of DNA that can occur
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
